Vanda Pharmaceuticals Inc.
VNDA
Jodie situation report
Vanda Pharmaceuticals Inc.'s move is being confirmed by its market group.
No new filing conclusion is available. 21 of 21 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.
- At least 14 of 21 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as CBLL begins moving with the group.
Invalidation: The live read weakens if participation falls to 7 of 21 members or fewer.
Who this business touches
The relationships behind VNDA
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
ANABAnaptysBio, Inc.partnerMay 7, 2026 ▾
“The three months ended March 31, 2025 included an upfront payment to AnaptysBio, Inc.”
TEVATeva Pharmaceutical Industries LimiteddistributorFeb 12, 2026 ▾
“For HETLIOZ ® in the treatment of Non-24, Teva and Apotex have launched their respective Abbreviated New Drug Application (ANDA) products at risk, and the FDA has also approved the ANDA for MSN.”
Depended on by
ANABAnaptysBio, Inc.partnerMay 12, 2026 ▾
“Vanda Collaboration On January 31, 2025, we entered into an Exclusive License Agreement (the “Vanda License Agreement”) with Vanda pursuant to which we granted to Vanda an exclusive, global license for the development and commercialization of imsidolimab (IL-…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 3 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
VNDA is currently a Participant in the organic co-movement group Oncology and Gastrointestinal Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.